Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value ($000): $197,364 (100.0% shares, 0.0% debt)

Holdings (7)

— EYEPOINT 38.0%

Value ($000) $75,018 Shares 41,909,219 Est. Cost $2.49 Unrealized —

AXGN AXOGEN INC 29.2%

Value ($000) $57,699 Shares 2,739,751 Est. Cost $4.01 Unrealized +356.0%

— REVANCE THERAPEUTICS INC 26.7%

Value ($000) $52,671 Shares 3,342,047 Est. Cost $31.50 Unrealized —

MNOV MEDICINOVA INC 4.9%

Value ($000) $9,691 Shares 1,170,370 Est. Cost $2.95 Unrealized +195.7%

— ENDOLOGIX INC 0.7%

Value ($000) $1,293 Shares 1,257,468 Est. Cost $18.00 Unrealized —

— CATALYST 0.3%

Value ($000) $640 Shares 78,622 Est. Cost $4.80 Unrealized —

ACUR ACURA PHARMACEUTICALS INC 0.2%

Value ($000) $352 Shares 1,956,397 Est. Cost $3.40 Unrealized -94.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	EYEPOINT	41,909,219	$75,018	38.0%	$2.49	—	COM	74440J101
AXGN	AXOGEN INC	2,739,751	$57,699	29.2%	$4.01	+356.0%	COM	05463X106
—	REVANCE THERAPEUTICS INC	3,342,047	$52,671	26.7%	$31.50	—	COM	761330109
MNOV	MEDICINOVA INC	1,170,370	$9,691	4.9%	$2.95	+195.7%	COM	58468P206
—	ENDOLOGIX INC	1,257,468	$1,293	0.7%	$18.00	—	COM	29266S106
—	CATALYST	78,622	$640	0.3%	$4.80	—	COM	14888D109
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$352	0.2%	$3.40	-94.4%	COM	00509L802